Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Velotab“
Suchtreffer
Begriffe & Kennungen
Zyprexa Velotab · 4.8 Undesirable effects · 1
Eintrag öffnenZyprexa Velotab · 4.8 · 1 Clinically significant weight gain was observed across all baseline Body Mass Index (BMI) categories. Follow
Eintrag öffnenZyprexa Velotab · 4.8 · 10 As assessed by measured values from clinical trials in the Olanzapine Integrated Database. 11 Adverse event
Eintrag öffnenZyprexa Velotab · 4.8 · 10 Investigations Elevated Increased alkaline Increased total plasma phosphatase10 bilirubin prolactin High cr
Eintrag öffnenZyprexa Velotab · 4.8 · 11 Long-term exposure (at least 48 weeks) The proportion of patients who had adverse, clinically significant c
Eintrag öffnenZyprexa Velotab · 4.8 · 12 25 % was common (2.5 %). With long-term exposure (at least 24 weeks), 89.4 % gained ≥ 7 %, 55.3 % gained ≥
Eintrag öffnenZyprexa Velotab · 4.8 · 8 Tabulated list of adverse reactions The following table lists the adverse reactions and laboratory investiga
Eintrag öffnenZyprexa Velotab · 4.8 · 9 Respiratory, thoracic and mediastinal disorders Epistaxis9 Gastrointestinal disorders Mild, transient Abdomi
Eintrag öffnenZyprexa Velotab · 4.8 · Additional information on special populations In clinical trials in elderly patients with dementia, olanzapine
Eintrag öffnenZyprexa Velotab · 4.8 · Adults The most frequently (seen in ≥ 1% of patients ) reported adverse reactions associated with the use of o
Eintrag öffnenZyprexa Velotab · 4.8 · Amnesia 9
Eintrag öffnenZyprexa Velotab · 4.8 · Dysarthria Stuttering11 Restless Legs Syndrome11 Cardiac disorders Bradycardia Ventricular QTc prolongation (s
Eintrag öffnenZyprexa Velotab · 4.8 · Dystonia (including oculogyration) 11 Tardive dyskinesia11
Eintrag öffnenZyprexa Velotab · 4.8 · Following short term treatment (median duration 22 days), weight gain ≥ 7% of baseline body 13
Eintrag öffnenZyprexa Velotab · 4.8 · High uric acid 10
Eintrag öffnenZyprexa Velotab · 4.8 · In clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with Parkinson’s dise
Eintrag öffnenZyprexa Velotab · 4.8 · In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted i
Eintrag öffnenZyprexa Velotab · 4.8 · Metabolism and nutrition disorders Very common: Weight gain13, elevated triglyceride levels14, increased appet
Eintrag öffnenZyprexa Velotab · 4.8 · Paediatric population Olanzapine is not indicated for the treatment of children and adolescent patients below
Eintrag öffnenZyprexa Velotab · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnen